Tag: JJ
J&J, following BMS, pledges $100 million to address racism and health...
Johnson & Johnson is reupping its commitment to addressing health inequities as the pandemic lays bare long-standing divisions. It's pledged $100 million over the next...
J&J tops list of healthcare supply chains amid COVID vaccine effort—and...
With a range of COVID-19 vaccine candidates nearing the finish line, more eyes are turning to the strength of drugmakers' supply chains to meet...
J&J moving to settle 1,000 talc lawsuits for more than $100M:...
Battling more than 20,000 lawsuits alleging its talc powder causes cancer, Johnson & Johnson is moving to settle more than 1,000 suits for about $100 million, Bloomberg reports.
J&J, which hasn’t faced a talc...
J&J wants everyone to know that taking care of their health...
Saying that a global pandemic is having a negative effect on people’s health seems obvious.
However, along with direct cases of COVID-19, there is concern...
J&J to buy Momenta Pharmaceuticals for $6.5B
Drugmaker Johnson & Johnson plans to spend a hefty sum to acquire a company focused on developing drugs for certain autoimmune diseases.
New Brunswick, New...
J&J scores Ebola vaccine approval in Europe. Can the platform win...
Johnson & Johnson has spent years building up its vaccine capabilities, and amid the coronavirus pandemic, its work in the field has taken on new...
Moderna, AstraZeneca and J&J coronavirus shots rev up for NIH tests...
As leading coronavirus vaccines make their way through early stages of human testing, the NIH is plotting much larger efficacy studies this summer. U.S. researchers plan to...
Legend aims for $100M IPO as partner J&J mulls outpatient use...
The Chinese company that originally created a CAR-T for multiple myeloma now under clinical development by Johnson & Johnson is planning to go public,...
